Subscribe
shutterstock_1397823521_pavel_kapysh
Pavel Kapysh / Shutterstock.com
27 September 2022BiotechnologyStaff Writer

Bio-Techne takes patent dispute to UK

The lawsuit centres on patented molecular instruments | The patents-in-suit cover cover features of RNAscope tech.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Biotechnology
LES 2015: ‘Much unrest’ in molecular diagnostics area, argues Roche
28 October 2015   There is “clearly a lot of unrest” in the patent law on molecular diagnostics, according to the head of licensing at Roche Diagnostics.
Americas
Pfizer acquires AstraZeneca’s small molecule anti-infective business
25 August 2016   Pharmaceutical company Pfizer has acquired AstraZeneca’s small molecule anti-infective business.


Editor's picks

Americas
UPC bans Meril Life Sciences from selling infringing heart valve
19 November 2024

Editor's picks

Americas
UPC bans Meril Life Sciences from selling infringing heart valve
19 November 2024
Americas
Big Pharma counsel embrace AI but data and legal risks loom
24 October 2024
Asia
President Xi sends message to AIPPI’s World Congress
22 October 2024
Unified Patent Court
‘Every CMS filing is painful’: Notes from a Unified Patent Court dispute
26 September 2024
Unified Patent Court
Interview: Klaus Grabinski, UPC Court of Appeal president
24 September 2024
Unified Patent Court
‘Be prepared, and don’t assume at the UPC’: Christopher Stothers
12 September 2024

More on this story

Biotechnology
LES 2015: ‘Much unrest’ in molecular diagnostics area, argues Roche
28 October 2015   There is “clearly a lot of unrest” in the patent law on molecular diagnostics, according to the head of licensing at Roche Diagnostics.
Americas
Pfizer acquires AstraZeneca’s small molecule anti-infective business
25 August 2016   Pharmaceutical company Pfizer has acquired AstraZeneca’s small molecule anti-infective business.

More on this story

Biotechnology
LES 2015: ‘Much unrest’ in molecular diagnostics area, argues Roche
28 October 2015   There is “clearly a lot of unrest” in the patent law on molecular diagnostics, according to the head of licensing at Roche Diagnostics.
Americas
Pfizer acquires AstraZeneca’s small molecule anti-infective business
25 August 2016   Pharmaceutical company Pfizer has acquired AstraZeneca’s small molecule anti-infective business.

More features

Bayer gains exclusive licence for heart drug in Japan
EPO delivers key Novo Nordisk, GSK and Inhibrx rulings
McGuireWoods expands team with ex-Novo Nordisk GC
Paul, Weiss swoops for senior duo from Weil, Gotshal
UPC bans Meril Life Sciences from selling infringing heart valve
SCOTUS denies Alvogen unit's appeal to sell Bausch Xifaxan generic
Kathi Vidal to rejoin previous firm as partner following USPTO departure
GSK triumphs in EPO appeal, revoking Pfizer patent